1-93154751-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_016040.5(TMED5):āc.609A>Gā(p.Leu203Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000813 in 1,614,130 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.00062 ( 0 hom., cov: 32)
Exomes š: 0.00083 ( 17 hom. )
Consequence
TMED5
NM_016040.5 synonymous
NM_016040.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.806
Genes affected
TMED5 (HGNC:24251): (transmembrane p24 trafficking protein 5) Involved in Golgi ribbon formation. Located in cis-Golgi network; endoplasmic reticulum exit site; and endoplasmic reticulum-Golgi intermediate compartment. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 1-93154751-T-C is Benign according to our data. Variant chr1-93154751-T-C is described in ClinVar as [Benign]. Clinvar id is 746730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.806 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 17 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMED5 | NM_016040.5 | c.609A>G | p.Leu203Leu | synonymous_variant | 4/4 | ENST00000370282.8 | NP_057124.3 | |
TMED5 | NM_001167830.2 | c.*76A>G | 3_prime_UTR_variant | 5/5 | NP_001161302.1 | |||
TMED5 | NR_030761.2 | n.851A>G | non_coding_transcript_exon_variant | 5/5 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000618 AC: 94AN: 152184Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
94
AN:
152184
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00170 AC: 427AN: 251470Hom.: 7 AF XY: 0.00224 AC XY: 304AN XY: 135908
GnomAD3 exomes
AF:
AC:
427
AN:
251470
Hom.:
AF XY:
AC XY:
304
AN XY:
135908
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000833 AC: 1218AN: 1461828Hom.: 17 Cov.: 30 AF XY: 0.00117 AC XY: 851AN XY: 727218
GnomAD4 exome
AF:
AC:
1218
AN:
1461828
Hom.:
Cov.:
30
AF XY:
AC XY:
851
AN XY:
727218
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000617 AC: 94AN: 152302Hom.: 0 Cov.: 32 AF XY: 0.000739 AC XY: 55AN XY: 74470
GnomAD4 genome
AF:
AC:
94
AN:
152302
Hom.:
Cov.:
32
AF XY:
AC XY:
55
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 13, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at